Mr. Chua joined the former Singapore Technologies Group in 1987 where he was involved in the early phase of Singapore Technologies’ venture capital investments which became Vertex in 1988. Throughout his career in Vertex, he has been involved in investments globally particularly in the US, Singapore, Taiwan, China and Israel. He spent several years in the US from 1989 to 1992 and later from 1998 to 2004 where he was head of Vertex US office. Mr. Chua currently heads Vertex’s investment in India, Singapore, Korea and SE Asia.
Prior to Singapore Technologies Group, Mr. Chua was with the NatSteel Group where he was involved in venture capital investments and corporate project development activities. He worked in the Singapore Economic Development Board and the Singapore subsidiary of General Electric’s semiconductor division after graduating from the University of Singapore in 1979 with a Bachelor of Engineering (Mechanical). He also has a MBA from National University of Singapore.
Mr. Chua currently serves on the Board of muvee Technologies Pte Ltd, eGInnovations Pte Ltd, Reverse Logistic Co. Pvt Ltd, Anhui Bayi Chemical Co Ltd and Shandong Huaan New Materials Co Ltd. His past directorships include UTAC, Spreadtrum Communication, Silknet and others. He is also currently a member of both the Evaluation Panel for NRF POC Grant Scheme and the Advisory Board/Selection Committee of SMART Innovation Center.
22-23 AUGUST 2017 | SEOUL, S.KOREA | PRESENTATION & BOOTH #3Learn More
NewsGenomeWeb Feature: John Wayne Cancer Institute and Clearbridge BioMedics announce partnership to develop CTC CoRE in the U.S. PR Newswire: John Wayne Cancer Institute, and Clearbridge BioMedics announce partnership to develop Circulating Tumor Cell Centre of Research Excellence in the U.S. BioSpectrum: John Wayne Cancer Institute and Clearbridge BioMedics announce partnership
22-23 AUGUST 2017 | SEOUL, S.KOREA | PRESENTATION & BOOTH #3Read more